Alcon, Inc.

Alcon Research, Ltd.

Purewine Inc.

Novartis Ag

University of Florida Research Foundation, Incorporated

Sentinel Diagnostic Imaging, Inc.

Halliburton Energy Services, Inc.

David L Meadows

Howard Allen Ketelson

James W Davis

Nissanke L Dassanayake

Rekha Rangarajan

Howard Ketelson

Derek B Meadows

Thomas Christopher Carey

Elaine E Campbell

Ronald L Schlitzer

Morgan Beeson

Daniel John Dickrell, Iii

Mutlu Karakelle

Xin Hong

Robert Phillip Darbe

Bor-Shyue Hong

Qiwen Zhan

Keith Douglas Pewitt

Richard D Clark, Iii

John C Baker

Robert Sawler

Jang-Shing Chiou

Derek Meadows

The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface.

Ophthalmic emulsion

Treating a non-wine alcoholic beverage including: exposing the non-wine alcoholic beverage to an ion exchange matrix. The ion exchange matrix includes a mixture of cation exchange media and anion exchange media that includes: (1) cation exchange media that are in hydrogen form, (2) cation exchange media that are in mineral form comprising potassium mineral form, (3) anion exchange media that are in hydroxide form, and (4) anion exchange media that are in chloride mineral form. The exposing results in: binding ions of the mixture to one or more cationic or anionic constituents present in the pretreated beverage, reducing concentrations of the one or more cationic or anionic constituents in the beverage and maintaining a conductivity value of the treated beverage equal to or greater than the pretreated beverage's conductivity value. An apparatus for treating a non-wine alcoholic beverage and a treated non-wine alcoholic beverage prepared by a process are also disclosed.

Method and apparatus for treating and producing non-wine alcoholic beverages with reduced noxious constituents

The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the compositions also comprise a borate compound.

Ophthalmic compositions with improved dessication protection and retention

The present invention relates to artificial tear compositions and ophthalmic compositions suitable for drug delivery. In one embodiment of the present invention, the compositions comprise a galactomannan polymer such as guar or hydroxypropyl guar, hyaluronic acid, and a cis-diol such as sorbitol. In a preferred embodiment, the to compositions also comprise a borate compound.

Beverage filtration device including a lid body having an internal housing configured to hold an ion exchange resin-filed cartridge therein having a connection end and a top end having an opening therein, and, stem body having a cap region, collar, beverage conduit and stem air tube. The cap region couples to the connection end of the lid body to form a liquid-tight seal coupling there-between. A collar wall first portion fits inside a beverage mouth container and a second portion located outside of the mouth. The beverage conduit spans the collar, a first conduit opening open to the coupling between the cap region and the connection end and a second conduit open to a container interior. The stem body air tube extends through the collar, a proximal opening of the stem body air tube opens to an air vent hole located in the second portion of the collar wall, and, a distal opening of the stem body air tube opens to the container interior.

Beverage filtration device

A method of treating an beverage, comprising exposing a beverage to an ion exchange matrix that includes a mixture of cation exchange beads and anion exchange beads each capable of binding to one or more cationic or anionic constituents present in the beverage and thereby reduce concentrations of the one or more cationic or anionic constituents in the beverage and capable of maintaining a pH of the beverage within &#xb1;0.5 pH units of the beverage's pretreatment pH value. The cationic or anionic constituents have a noxious effect on humans and the cation exchange beads include a cationic mineral form and the anion exchange beads include a chloride mineral form.

Treatment of beverages to reduce the effects of noxious constituents

Beverage treatment device

Disclosed herein is a method comprising imaging a network section through which flow occurs; where the flow is selected from a group consisting of fluid, electrons, protons, neutrons and holes; partitioning the image into sub-regions based on metabolic need and function; where each region comprises one or more sources and one or more sinks; where the flow emanates from the source and exits into the sinks; performing a Delaunay triangulation tessellation on one or more sub-regions by connecting one or more sources and one or more sinks; where the Delaunay triangulations maximize the minimum angle of all the angles of the triangles in the triangulation; generating a Voronoi diagram from the Delaunay triangulation by subdividing the sub-regions into Voronoi cells, where each Voronoi cell contains exactly one sink or one source; and where the intersections of Voronoi cells are Voronoi cell vertices; locating a sink endpoint centroid; connecting a source to a nearest Voronoi cell vertex; connecting at least one sink to at least one of the remaining Voronoi cell vortices to complete the network; and performing a smoothing function on the network to form a smoothed network.

System and method for diagnosing defects in random flow systems

Disclosed herein is a method comprising a method comprising imaging a network section through which flow occurs; where the flow is selected from a group consisting of fluid, electrons, protons, neutrons and holes; partitioning the image into sub-regions based on metabolic need and function; where each region comprises one or more sources and one or more sinks; where the flow emanates from the source and exits into the sinks; generating a Voronoi diagram from the Delaunay triangulation by subdividing the sub-regions into Voronoi cells, where each Voronoi cell contains exactly one sink or one source; and where the intersections of Voronoi cells are Voronoi cell vertices; calculating a flow rate in each Voronoi cell; and according a color to Voronoi cells based on their flow rates; where Voronoi cells having similar rates are accorded similar colors.

System for diagnosing disease using spatial area normalization analysis

Growing community of inventors

Colleyville, TX, United States of America

David L Meadows